8-32754452-G-T
Position:
Variant summary
Our verdict is Benign. Variant got -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBS1BS2
The NM_013964.5(NRG1):c.781G>T(p.Val261Leu) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.04 in 1,613,700 control chromosomes in the GnomAD database, including 1,518 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Genomes: 𝑓 0.031 ( 111 hom., cov: 32)
Exomes 𝑓: 0.041 ( 1407 hom. )
Consequence
NRG1
NM_013964.5 missense
NM_013964.5 missense
Scores
5
5
8
Clinical Significance
Conservation
PhyloP100: 10.0
Genes affected
NRG1 (HGNC:7997): (neuregulin 1) The protein encoded by this gene is a membrane glycoprotein that mediates cell-cell signaling and plays a critical role in the growth and development of multiple organ systems. An extraordinary variety of different isoforms are produced from this gene through alternative promoter usage and splicing. These isoforms are expressed in a tissue-specific manner and differ significantly in their structure, and are classified as types I, II, III, IV, V and VI. Dysregulation of this gene has been linked to diseases such as cancer, schizophrenia, and bipolar disorder (BPD). [provided by RefSeq, Apr 2016]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -14 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.0050670207).
BP6
Variant 8-32754452-G-T is Benign according to our data. Variant chr8-32754452-G-T is described in ClinVar as [Likely_benign]. Clinvar id is 1285094.Status of the report is criteria_provided_single_submitter, 1 stars. Variant chr8-32754452-G-T is described in Lovd as [Benign].
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.0312 (4756/152222) while in subpopulation NFE AF= 0.0463 (3150/68018). AF 95% confidence interval is 0.045. There are 111 homozygotes in gnomad4. There are 2218 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High AC in GnomAd4 at 4756 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NRG1 | NM_013964.5 | c.781G>T | p.Val261Leu | missense_variant | 8/12 | ENST00000405005.8 | NP_039258.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NRG1 | ENST00000405005.8 | c.781G>T | p.Val261Leu | missense_variant | 8/12 | 1 | NM_013964.5 | ENSP00000384620.2 |
Frequencies
GnomAD3 genomes AF: 0.0313 AC: 4757AN: 152104Hom.: 111 Cov.: 32
GnomAD3 genomes
AF:
AC:
4757
AN:
152104
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0299 AC: 7494AN: 251018Hom.: 159 AF XY: 0.0303 AC XY: 4104AN XY: 135646
GnomAD3 exomes
AF:
AC:
7494
AN:
251018
Hom.:
AF XY:
AC XY:
4104
AN XY:
135646
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0409 AC: 59771AN: 1461478Hom.: 1407 Cov.: 31 AF XY: 0.0402 AC XY: 29191AN XY: 727024
GnomAD4 exome
AF:
AC:
59771
AN:
1461478
Hom.:
Cov.:
31
AF XY:
AC XY:
29191
AN XY:
727024
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0312 AC: 4756AN: 152222Hom.: 111 Cov.: 32 AF XY: 0.0298 AC XY: 2218AN XY: 74424
GnomAD4 genome
AF:
AC:
4756
AN:
152222
Hom.:
Cov.:
32
AF XY:
AC XY:
2218
AN XY:
74424
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
186
ALSPAC
AF:
AC:
188
ESP6500AA
AF:
AC:
47
ESP6500EA
AF:
AC:
405
ExAC
AF:
AC:
3463
Asia WGS
AF:
AC:
19
AN:
3476
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:3
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Benign:2
Benign, no assertion criteria provided | clinical testing | Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center | - | - - |
Benign, no assertion criteria provided | clinical testing | Genome Diagnostics Laboratory, University Medical Center Utrecht | - | - - |
not provided Benign:1
Likely benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Benign
T
BayesDel_noAF
Uncertain
CADD
Pathogenic
DANN
Uncertain
DEOGEN2
Benign
.;.;T;.;.;.;.;T;.;.;T
Eigen
Pathogenic
Eigen_PC
Pathogenic
FATHMM_MKL
Pathogenic
D
LIST_S2
Benign
.;T;T;D;T;T;T;T;D;T;D
MetaRNN
Benign
T;T;T;T;T;T;T;T;T;T;T
MetaSVM
Benign
T
MutationAssessor
Benign
.;.;.;.;.;L;.;L;.;.;.
PrimateAI
Pathogenic
D
PROVEAN
Benign
N;N;N;N;.;N;.;N;N;.;N
REVEL
Uncertain
Sift
Uncertain
D;D;D;D;.;D;.;D;D;.;D
Sift4G
Uncertain
D;D;D;D;D;D;D;D;D;D;T
Polyphen
0.96, 0.99, 0.98, 0.95
.;.;.;.;D;D;D;P;.;.;.
Vest4
0.33, 0.80, 0.77, 0.81, 0.60, 0.78, 0.76
MutPred
0.62
.;.;.;.;.;Loss of MoRF binding (P = 0.1129);.;Loss of MoRF binding (P = 0.1129);.;.;.;
MPC
0.60
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at